Unlock key insights and practical strategies in the management of primary biliary cholangitis (PBC) at this dynamic, case-based "Medscape Clinic style" symposium. Hear from expert faculty as they discuss the latest in PBC diagnosis, risk assessment, treatment selection, setting goals with patients, and other important topics. Through interactive discussions and real-world cases, you'll come away with a better understanding of comprehensive PBC management that you can apply to your own patients in the clinic. Don't miss this opportunity to advance your expertise and elevate outcomes for your patients with PBC.

• CE: 1.25 CME Hours
• Supported by: Ipsen Biopharmaceuticals, Inc.
• Organized by: Medscape Education
• For more information and to register, visit: https://events.medscapelive.org/website/99143/

Unlocking The Potential of a Liver-Directed Treatment, The First and Only treatment for MASH with moderate to advanced fibrosis that activates THR-B.

Industry Supporter: Madrigal 

This is a healthy liver, healthy lives (HLHL) symposium bringing the global community together to elevate alcohol-associated liver disease as a global public policy priority.

Join our Boehringer Ingelheim-sponsored Product Theater to hear more about the role of the liver in metabolic dysfunction, including a discussion on the broader impact beyond the liver from a leading endocrinologist. Our esteemed panel will also highlight the latest in MASLD/MASH patient management and answer your questions.

Industry Supporter: Boehringer Ingelheim Pharmaceuticals, Inc.

During this interactive session, Drs Arun Sanyal and Kris Kowdley will be highlighting current gaps in the management of steatotic liver disease, reviewing the mechanisms of FGF21 analogs in MASH and discussing the clinical evidence for FGF21 analogs in MASH management. 

Industry Supporter: Novo Nordisk
 

Join us for a focused look at clinical data from a phase 3 trial, detailing the 72-week efficacy and safety of a treatment for adults with noncirrhotic MASH and moderate to advanced fibrosis. The session will outline how these results may support care for appropriate patients with this chronic liver disease.

Industry Supporter: Novo Nordisk, Inc.

Join transplant hepatologist Dr. Brett Fortune and interventional radiologist Dr. Bartley Thornburg as they share real-world experience and case studies using small diameter TIPS. Explore how stent options for patients with ascites and variceal bleeding are influencing patient selection, referral timing, complications like HE, and procedural outcomes.

Industry Supporter: Educational Discussion Supported by W. L. Gore & Associates

Through interactive expert discussion, Drs. Noureddin, Loomba, and Mellinger will explore the advanced liver disease continuum and prognostic importance of fibrosis, review metabolic drivers and the role of alcohol in advanced liver disease progression, and highlight patient-centered approaches to integrated AUD and ALD care.

Industry Supporter: Altimmune

Join us for a product theater on an FDA-approved treatment option for primary biliary cholangitis (PBC). Gain insights into how this therapy may support improved PBC outcomes for the appropriate patients affected by this chronic liver disease.

Industry Supporter: Gilead Science, Inc.

What can patients living with primary biliary cholangitis (PBC) teach us about how they successfully manage the condition? Hear expert and patient perspectives on practical ways to recognize, assess and monitor PBC symptoms to better inform patient-centered care.

Industry Supporter: Ipsen